Assyro AI
FDA 483 Database

FDA Form 483s Issued in July 2023

Every published Form FDA 483 issued in July 2023, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

7

Published 483s in July 2023

7

Distinct firms

Form 483s issued in July 2023

Sentara EnterprisesFDA
FEI
3025984445
Issued
Jul 14, 2023
Establishment
Producer of Sterile Drug Products
Location
Virginia, United States
Central Admixture Pharmacy Services, Inc.FDA
FEI
3014307835
Issued
Jul 31, 2023
Establishment
Outsourcing Facility
Location
Arizona, United States
New Vitalis Pharmacy LLCFDA
FEI
3014391500
Issued
Jul 5, 2023
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
Kentucky, United States
UCB Farchim SAFDA
FEI
3005023799
Issued
Jul 4, 2023
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
Switzerland
Surgery Pharmacy Services IncFDA
FEI
3010704905
Issued
Jul 7, 2023
Establishment
Producer of Sterile Drug Products
Location
Tennessee, United States
Novo Nordisk Pharmaceutical Industries LPFDA
FEI
1000158576
Issued
Jul 13, 2023
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
North Carolina, United States
Biocon Sdn. Bhd.FDA
FEI
3011248248
Issued
Jul 20, 2023
Establishment
Finished Pharmaceutical Manufacturer
Location
Malaysia

Other months in 2023

Back to the FDA 483 Database